JAK抑制剂巴瑞替尼治疗环状肉芽肿1例

doi:10.35541/cjd.20210709

Abstract

Hou Xiaoyuan, Wu Nanhui, Xu Mingyuan, Liu Yeqiang. A case of granuloma annulare treated with the JAK inhibitor baricitinib[J]. Chinese Journal of Dermatology, 2024, 57(5): 461-462.doi:10.35541/cjd.20210709

References ［7］

［1］	Imadojemu S, Rosenbach M. Advances in inflammatory granulomatous skin diseases［J］. Dermatol Clin, 2019,37（1）:49⁃64. doi: 10.1016/j.det.2018.08.001.
［2］	Chapman S, Gold LS, Lim HW. Janus kinase inhibitors in dermatology: part II. A comprehensive review［J］. J Am Acad Dermatol, 2022,86（2）:414⁃422. doi: 10.1016/j.jaad.2021.06.873.
［3］	Mempel M, Musette P, Flageul B, et al. T⁃cell receptor repertoire and cytokine pattern in granuloma annulare: defining a particular type of cutaneous granulomatous inflammation［J］. J Invest Dermatol, 2002,118（6）:957⁃966. doi: 10.1046/j.1523⁃1747.2002. 01783.x.
［4］	Min MS, Wu J, He H, et al. Granuloma annulare skin profile shows activation of T⁃helper cell type 1, T⁃helper cell type 2, and Janus kinase pathways［J］. J Am Acad Dermatol, 2020,83（1）:63⁃70. doi: 10.1016/j.jaad.2019.12.028.
［5］	Wang A, Rahman NT, Mcgeary MK, et al. Treatment of granuloma annulare and suppression of proinflammatory cytokine activity with tofacitinib［J］. J Allergy Clin Immunol, 2021,147（5）:1795⁃1809. doi: 10.1016/j.jaci.2020.10.012.
［6］	Chu CY. New targets in treating granuloma annulare［J］. J Allergy Clin Immunol, 2021,147（5）:1646⁃1647. doi: 10.1016/j.jaci.2021.03.003.
［7］	Damsky W, Thakral D, McGeary MK, et al. Janus kinase inhibition induces disease remission in cutaneous sarcoidosis and granuloma annulare［J］. J Am Acad Dermatol, 2020,82（3）:612⁃621. doi: 10.1016/j.jaad.2019.05.098.

[1]	China Dermatologist Association, Combination of Traditional and Western Medicine Dermatology. Diagnosis and treatment of erythrodermic psoriasis: a Chinese expert consensus statement （2024） [J]. Chinese Journal of Dermatology, 2024, 57(5): 409-417.
[2]	Mycology Group, Combination of Traditional and Western Medicine Dermatology, Chinese Antifungal-Resistant Dermatophytosis Expert Consensus Group. Expert consensus on the diagnosis, treatment, prevention and control of antifungal-resistant dermatophyte infections in China （2024） [J]. Chinese Journal of Dermatology, 2024, 57(5): 418-425.
[3]	Liu Yi, Qu Ying, Lei Wenzhi, Liu Xiaogang, Pan Weihua, Zhang Chao. Clinical efficacy of salt-packing therapy in the treatment of pyogenic granuloma [J]. Chinese Journal of Dermatology, 2024, 0(4): 20230553-e20230553.
[4]	Ju Qiang, Li Jiaqi. Acne vulgaris revisited: from pathogenesis to treatment strategies [J]. Chinese Journal of Dermatology, 2024, 57(4): 289-294.
[5]	Zhang Dimin, Cao Cheng, Zhou Miaoni, Sheng Anqi, Lin Fuquan, Xu Ai′e. Analysis of disease control rate and its influencing factors in patients with progressive non-segmental vitiligo after combined treatment with compound betamethasone injection [J]. Chinese Journal of Dermatology, 2024, 57(4): 350-354.
[6]	Tian Jing, Deng Sisi, Song Zhiqiang . A comparison of clinical characteristics between atopic and non-atopic prurigo nodularis [J]. Chinese Journal of Dermatology, 2024, 57(4): 331-337.
[7]	Song Yuqing, Yang Nan, Liu Linlin, Feng Ziyi, Han Shixin, Zhou Meijuan. Dermabrasion for the treatment of familial benign chronic pemphigus: a clinical observation of 6 cases [J]. Chinese Journal of Dermatology, 2024, 0(4): 20220278-e20220278.
[8]	Ge Xinhong, Ma Yingdong, Jiao Yaning, Liu Lingling, Zhou Mei, Zi Wei, Li Bowen. Analysis of efficacy and safety of 532-nm picosecond laser in the treatment of early-stage facial seborrheic keratosis [J]. Chinese Journal of Dermatology, 2024, 57(4): 359-362.
[9]	Wang Liuyuan, Zhang Xiaohui, Luo Danyang, Ke Wujian, Xue Yaohua, Huang Jinmei, Li Changchang, Zhao Peizhen, Yang Ligang, . A survey on the current status of standardized diagnosis and treatment services for sexually transmitted diseases in medical institutions in Guangdong province [J]. Chinese Journal of Dermatology, 2024, 57(3): 218-223.
[10]	Wang Yukun, Liu Jie. Application of deep learning in non-neoplastic dermatoses [J]. Chinese Journal of Dermatology, 2024, 0(3): 20220660-e20220660.
[11]	Zhang Jin, Chen Shaochun, Yin Yueping. Promising treatment options for antibiotic-resistant Neisseria gonorrhoeae [J]. Chinese Journal of Dermatology, 2024, 57(3): 272-275.
[12]	Li Fang, Lin Ying. Diagnosis and treatment of atopic dermatitis of the head and neck [J]. Chinese Journal of Dermatology, 2024, 0(3): 20230562-e20230562.
[13]	Guliziba·Tuersun, Qu Yuanyuan. New advances in the treatment of vitiligo with JAK-STAT inhibitors [J]. Chinese Journal of Dermatology, 2024, 57(1): 71-75.
[14]	Zhang Qian, Zhang Jin′e, Guo Sen, Song Pu, Gao Lin, Li Chunying. Comparison of the efficacy of fractional CO2 laser combined with topical delivery of fluorouracil versus compound betamethasone injections in the treatment of vitiligo: a clinical observation [J]. Chinese Journal of Dermatology, 2024, 57(1): 34-38.
[15]	Xuan Yijie, Yang Yiwen, Wang Chen, Xu Zhongyi, Xiang Leihong, Zhang Chengfeng. Investigation of clinical factors influencing the response to systemic glucocorticoid treatment in patients with progressive non-segmental vitiligo [J]. Chinese Journal of Dermatology, 2024, 57(1): 17-22.

A case of granuloma annulare treated with the JAK inhibitor baricitinib

PDF

PDF (Mobile)

Knowledge

Abstract

Cite this article

share this article

References ［7］

Related Articles 15

Metrics

Comments

Recommended 10